Centessa, formed earlier this year through a ten-way merger involving multiple spinouts, has completed a listing in the US.

Centessa Pharmaceutical, a UK-based pharmaceutical conglomerate formed through a ten-way merger involving spinouts from various universities, went public in a $330m initial public offering on Friday. The company issued 16.5 million American Depositary Shares, representing the same number of ordinary shares, priced at $20 each. The spinout now trades on the Nasdaq Global Select Market…

The rest of this content is only accessible to University Venturing: News, Data, and Events - Global University Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.